TerminatedPhase 2NCT00004466
Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
Studying Rare hyperlipidemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Ronald Hogg, M.DSouthwest Pediatric Nephrology Study Group
- Intervention
- Atorvastatin(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 6-17 years · All sexes
- Timeline
- 1998 – 1999
Study locations (1)
- Medical City Dallas Hospital, Dallas, Texas, United States
Collaborators
Southwest Pediatric Nephrology Study Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004466 on ClinicalTrials.gov